For the first time in the world, a collaborative research team at Nagoya University has shown to the world that intraperitoneal administration of a plasma active solution to cancer cells scattered in the abdominal cavity of mice suppresses the progression of cancer and significantly prolongs survival. rice field.This result was published in the British magazine "Scientific Reports" on July 2017, 7 (electronic version).
The group has reported that a plasma active solution made using an ultra-high density plasma generator developed independently has an antitumor effect on ovarian cancer, brain tumor, and gastric cancer, and is directly irradiated with plasma. We have demonstrated many usefulnesses as a treatment for cancers that cannot be done.
This time, using a mouse ovarian cancer peritoneal dissemination model, which is an animal individual that is closer to the actual pathological condition, the cancer cells scattered in the abdominal cavity become difficult to adhere by administering a plasma active solution and delay the cancer progression. It was shown that the survival time was significantly extended.
The finding that it suppresses the progression of cancer by reducing the adhesive ability of cancer cells for cancer accompanied by dissemination is completely different from the cancer cell killing effect by apoptosis that has been said so far. It's a different mechanism.
Nagoya University has already succeeded in developing a plasma-active infusion solution for clinical application.The results of this research are useful findings for clinical application, and it can be said that they have made great strides toward the practical application of plasma active solutions.
Paper information:[Scientific Reports] Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
